MoonLake Immunotherapeutics Class A (MLTX) is currently at $48.03, up $6.87 or 16.69%
--Would be highest close since Jan. 8, 2025, when it closed at $48.17
--On pace for largest percent increase since June 26, 2023, when it rose 77.55%
--Currently up four consecutive days; up 25.83% over this period
--Longest winning streak since April 21, 2025, when it rose for six straight trading days
--Best four-day stretch since the four days ending June 29, 2023, when it rose 97.37%
--Down 11.3% year-to-date
--Down 24.79% from its all-time closing high of $63.86 on Feb. 12, 2024
--Up 17.69% from 52 weeks ago (June 4, 2024), when it closed at $40.81
--Down 14.69% from its 52-week closing high of $56.30 on Dec. 17, 2024
--Up 46.28% from its 52-week closing low of $32.84 on April 8, 2025
--Traded as high as $49.29; highest intraday level since Jan. 8, 2025, when it hit $50.50
--Up 19.75% at today's intraday high; largest intraday percent increase since June 26, 2023, when it rose as much as 102.18%
All data as of 10:46:39 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 03, 2025 10:54 ET (14:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。